studi
influenc
linker
rigid
donoracceptor
properti
pch
ochrfrag
acycl
nucleosid
phosphon
eg
acyclovir
tenofovir
replac
pch
hnc
residu
respect
phosphon
synthes
good
yield
coupl
straight
chain
xaminophosphon
nucleobasederiv
acet
acid
edc
base
h
c
nmr
data
unrestrict
rotat
within
methylen
linker
phosphon
seri
b
confirm
phosphon
contain
seri
c
fragment
antiperiplanar
disposit
bulki
odiethylphosphon
substitut
amidomethyl
group
establish
synthes
anp
pxhnc
ch
b
x
ch
ch
ch
ch
ch
ch
och
ch
appear
inact
antivir
assay
wide
varieti
dna
rna
virus
concentr
lm
margin
antiprolif
activ
cell
ic
lm
hela
cell
ic
lm
notic
analog
deriv
acet
acid
odiethyl
methylphosphon
h
n
x
eto
p
x
ch
ch
ch
ch
ch
ch
ch
och
ch
b
natur
modifi
nuclebas
search
new
compound
endow
antivir
activ
underway
decad
sever
research
group
activ
field
academia
pharmaceut
industri
despit
effort
mani
virus
effici
drug
yet
discov
addit
anticanc
drug
avail
far
exhibit
limit
applic
high
mutat
rate
observ
virus
make
issu
highli
complex
within
medic
appli
treat
viral
infect
acycl
nucleosid
phosphon
anp
play
import
role
prototyp
acycl
nucleosid
phosphon
anp
hpmpa
never
commerci
gave
rise
three
market
product
cidofovir
adefovir
tenofovir
often
prescrib
physician
far
known
structur
modif
compound
accomplish
within
chain
connect
nucleobas
phosphon
acid
moieti
lead
discoveri
analog
higher
antivir
activ
fig
analysi
mechan
action
anp
allow
conclud
within
structur
newli
design
andrzej
e
andrzejwroblewski
umedlodzpl
analog
anp
follow
fragment
instal
phosphon
unit
pch
prevent
enzymat
hydrolysi
po
bond
present
natur
phosphat
capabl
phosphoryl
canon
nucleobas
close
structur
heterocycl
system
assur
effici
interact
complementari
nucleobas
polynucleotid
chain
linker
adjust
distanc
nucleobas
phosphoru
atom
contain
four
atom
consid
optim
moment
take
account
high
antivir
activ
compound
one
may
interest
specif
interact
oxygen
lone
pair
also
entir
phosphonomethoxi
pch
fragment
oxygen
atom
locat
within
pch
ochrfrag
serv
lone
pair
donor
intermolecular
interact
singl
bond
connect
atom
linker
ensur
free
rotat
modifi
interact
atom
locat
linker
reason
consid
replac
select
fragment
linker
anoth
moieti
studi
biolog
activ
peptid
replac
amid
c
nh
residu
sever
isoster
fragment
includ
methylen
ether
ch
moieti
commonli
appli
particular
replac
allow
preserv
steric
conform
bond
system
essenti
influenc
donoracceptor
interact
possibl
rotat
around
specif
bond
within
linker
complet
free
around
ch
bond
kjmolbarri
rotat
compar
hinder
around
c
nh
bond
kjmolbarri
rotat
gener
isoster
replac
diminish
affin
modifi
peptid
comparison
natur
one
propos
structur
modif
anp
reli
incorpor
specif
fragment
abl
increas
donoracceptor
interact
within
linker
first
approach
pch
ochr
fragment
replac
amid
pch
hnc
residu
provid
amid
scheme
addit
part
linker
contain
amid
bond
becom
rigid
thu
may
influenc
activ
modifi
anp
sever
decad
ago
concept
phosphon
peptid
nucleic
acid
ppna
introduc
varieti
relat
monom
synthes
howev
limit
aminomethyland
aminoethylphosphon
deriv
interest
synthesi
phosphon
gener
formula
significantli
extend
structur
divers
potenti
new
monom
primarili
aminoalkylphosphon
fragment
herein
wish
describ
studi
synthesi
biolog
activ
amid
synthet
strategi
involv
format
amid
bond
respect
acet
acid
deriv
xaminophosphon
scheme
synthes
first
seri
amid
xaminophosphon
contain
straight
chain
linker
select
scheme
xaminophosphon
prepar
accord
describ
procedur
among
aminomethylphosphon
consid
import
sinc
later
transform
analog
nitrogen
atom
nucleobas
phosphoru
atom
separ
four
bond
thu
provid
compound
structur
closest
drug
uracil
thymin
benzouracil
also
known
compound
synthes
alkyl
respect
nucleobas
chloroor
bromoacet
acid
futur
introduct
cytosineand
adenineacetyl
fragment
protect
acid
prepar
significantli
increas
lipophil
respect
amid
acet
acid
serv
precursor
guaninedecor
amid
scheme
larg
number
coupl
reagent
develop
effici
format
amid
bond
prove
use
peptid
chemistri
search
coupl
system
appli
task
direct
studi
acyl
model
secondari
amin
acet
acid
aminophosphon
react
acid
presenc
dimethylamino
phosphonium
hexafluorophosph
bop
tripyrrolidinophosphonium
hexafluorophosph
pybop
n
dimethylamino
nmethylmethanaminium
hexafluorophosph
noxid
hatu
dimethylaminomorpholinomethylen
methanaminium
hexafluorophosph
comu
triethylamin
diethylisopropylamin
addit
expect
amid
could
isol
complex
reaction
mixtur
coupl
next
perform
propylphosphon
anhydrid
n
n
ethylcarbodiimid
hydrochlorid
edc
produc
pure
amid
accept
yield
tabl
expect
microwav
irradi
significantli
acceler
amid
bond
format
case
coupl
aminophosphon
nucleobasesubstitut
acet
acid
presenc
edc
proceed
almost
quantit
howev
final
product
isol
moder
yield
sinc
sever
crystal
necessari
remov
last
trace
triethylamin
hydrochlorid
guaninecontain
phosphon
prepar
precursor
hydrolysi
acid
medium
scheme
also
aim
studi
conform
behavior
acycl
linker
connect
phosphoru
atom
amid
nitrogen
futur
structureact
consider
free
rotat
around
pch
h
cnh
bond
phosphon
depict
fig
evidenc
vicin
hnch
coupl
hz
observ
spectra
taken
chloroformd
dmsod
respect
solut
solvent
well
methanold
h
cp
equival
sinc
alway
appear
one
doublet
twobond
hp
coupl
hz
structur
fig
summar
conform
flexibl
phosphon
prove
observ
vicin
h
cch
coupl
hz
sinc
c
nmr
spectra
phosphon
show
larg
valu
hz
vicin
pccc
coupl
antiperiplanar
disposit
pccch
group
propos
repres
newman
project
although
signific
valu
hz
observ
c
nmr
spectra
phosphon
vicin
pcoc
coupl
appli
confid
discuss
conform
behavior
ch
och
ch
linkag
sinc
angular
depend
within
pcoc
framework
yet
establish
phosphon
evalu
inhibitori
activ
wide
varieti
dna
rna
virus
use
follow
cellbas
assay
e
mdck
cell
cultur
influenza
viru
subtyp
influenza
b
viru
ganciclovir
cidofovir
acyclovir
brivudin
zalcitabin
zanamivir
alovudin
amantadin
rimantadin
ribavirin
dextran
sulfat
molecular
weight
mycophenol
acid
hippeastrum
hybrid
agglutinin
hha
urtica
dioica
agglutinin
uda
use
refer
compound
antivir
activ
express
ec
compound
concentr
requir
reduc
viru
plaqu
format
vzv
reduc
virusinduc
cytopathogen
virus
none
test
compound
show
appreci
antivir
activ
toward
test
dna
rna
virus
concentr
lm
affect
cell
morpholog
hel
hela
vero
mdcl
crfk
cell
cytostat
inhibitori
concentr
ic
caus
decreas
cell
prolifer
determin
hela
cell
ic
lm
thu
enlarg
collect
deriv
togeth
parent
compound
wide
clinic
appli
therapi
variou
cancer
furthermor
closest
structur
analog
compound
found
activ
vitro
cell
concentr
lm
fig
replac
pch
ochrfrag
anp
eg
acyclovir
tenofovir
pch
hnc
residu
introduc
studi
influenc
linker
rigid
chang
donoracceptor
properti
elabor
appropri
synthet
methodolog
seri
respect
phosphon
odiethyl
ester
prepar
good
yield
edcinduc
coupl
straight
chain
xaminophosphon
nucleobasederiv
acet
acid
besid
rigid
amid
bond
base
h
c
nmr
data
conclud
unrestrict
rotat
within
methylen
seri
seri
b
linker
take
place
phosphon
contain
seri
c
fragment
antiperiplanar
disposit
bulki
odiethylphosphon
substitut
amidomethyl
group
observ
phosphon
appear
inact
antivir
assay
wide
varieti
dna
rna
virus
concentr
lm
margin
antiprolif
activ
ic
lm
hela
ic
lm
notic
phosphon
deriv
acet
acid
odiethyl
methylphosphon
studi
analog
phosphon
contain
function
linkag
current
ongo
laboratori
activ
diethyl
ester
transform
free
anp
derivat
select
prodrug
phosphon
experiment
h
nmr
spectra
record
cd
od
cdcl
dmsod
follow
spectromet
varian
gemini
mhz
bruker
avanc
iii
mhz
tm
intern
standard
c
nmr
spectra
record
cd
od
cdcl
dmsod
solut
bruker
avanc
iii
mhz
p
nmr
spectra
perform
varian
gemini
mhz
bruker
avanc
iii
mhz
ir
spectral
data
measur
bruker
alphat
ftir
spectromet
melt
point
determin
boetiu
apparatu
element
analys
perform
microanalyt
laboratori
faculti
perkin
elmer
pe
chn
analyz
result
found
good
agreement
calcul
valu
follow
absorb
use
column
chromatographi
merck
silica
gel
mesh
analyt
tlc
merck
tlc
plastic
sheet
silica
gel
f
tlc
plate
develop
chloroformmethanol
solvent
system
visual
spot
effect
iodin
vapor
solvent
purifi
method
describ
literatur
gener
procedur
solut
g
aminophosphon
mmol
cm
dmf
contain
g
acet
acid
mmol
cool
cm
tea
mmol
follow
cm
solut
dmf
mmol
ad
reaction
mixtur
stir
room
temperatur
h
concentr
vacuo
treat
cm
water
solid
filter
air
dri
subject
chromatographi
silica
gel
column
chloroformmethanol
mixtur
vv
give
pure
compound
g
yield
white
powder
gener
procedur
b
solut
aminophosphon
mmol
cm
dmf
chloroform
respect
acet
acid
mmol
edc
hcl
mmol
tea
mmol
ad
reaction
mixtur
stir
room
temperatur
h
concentr
vacuo
residu
chromatograph
silica
gel
column
chloroformmethanol
mixtur
crystal
appropri
solvent
gener
procedur
c
solut
aminophosphon
mmol
cm
chloroform
respect
acet
acid
mmol
edc
hcl
mmol
tea
mmol
ad
reaction
mixtur
irradi
w
specifi
time
h
concentr
vacuo
residu
chromatograph
silica
gel
column
chloroformmethanol
mixtur
crystal
appropri
solvent
crude
product
obtain
g
diethyl
mmol
g
acet
acid
